New Psychedelic Drug Shows 71% Cure Rate for Postpartum Depression

A groundbreaking clinical trial shows luvesilocin, a psychedelic treatment, eliminated postpartum depression symptoms in 71% of new mothers after just one dose.

The FDA has fast-tracked the drug after researchers found it works better than any existing treatment for the 1 in 5 women who suffer from postpartum depression.